Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gliclazide (SE1702), an oral antihyperglycemic agent, belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating beta-cells of the pancreas to release insulin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 45.00 | |
1 g | In stock | $ 71.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Gliclazide (SE1702), an oral antihyperglycemic agent, belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating beta-cells of the pancreas to release insulin. |
Targets&IC50 | Potassium channel:184 nM |
Synonyms | S1702, SE1702 |
Molecular Weight | 323.41 |
Formula | C15H21N3O3S |
CAS No. | 21187-98-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 60 mg/mL (185.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gliclazide 21187-98-4 Membrane transporter/Ion channel Potassium Channel KcsA Inhibitor S-1702 inhibit S 1702 SE 1702 SE-1702 S1702 SE1702 inhibitor